Encapsulate Company

Personalized Cancer Screening. This project is a technology demonstration of Encapsulate's automated tumor-on-a-chip platform designed for growing patient-derived microtumors under controlled conditions outside the human body. Results will help validate an accelerated disease model in microgravity for the rapid screening of chemotherapeutic drugs for safety and efficacy against patient-specific tumors.
Industry: Risk Mitigation
Headquarters: USA
Founded Date: 2018
Total Funding: $0.96

Visit Website
Register and Claim Ownership